PepGen raises $113M to challenge Sarepta in DMD, build neuromuscular and neurologic pipeline fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
PepGen Announces Appointment of James McArthur, Ph.D., as President and Chief Executive Officer
February 4, 2021 GMT
PepGen Logo
BOSTON and OXFORD, England, Feb. 4, 2021 /PRNewswire/ PepGen, a biotechnology company focused on transforming the care of patients with neuromuscular diseases through the enhanced delivery of therapeutic oligonucleotides, today announced the appointment of James McArthur, Ph.D., as President and Chief Executive Officer (CEO). Dr. McArthur brings more than 25 years of experience as a co-founder of numerous biotech companies focused on rare disease therapeutics. He joins the PepGen team at a time of rapid growth following its successful $45 million Series A financing at the end of 2020, which was led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), CureDuchenne Ventures, and the University of Oxford.